ClinicalTrials.Veeva

Menu

Caries Prevention Potential of Pearl Powder Versus CPP-ACP on Enamel White Spot Lesions

R

Ruba Alaa El Din Adel El Damarisy

Status and phase

Unknown
Phase 2

Conditions

White Spot Lesion of Tooth

Treatments

Other: pearl powder
Drug: CPP-ACP

Study type

Interventional

Funder types

Other

Identifiers

NCT03973554
11090 (Registry Identifier)

Details and patient eligibility

About

to evaluate the caries prevention potential of pearl powder against CPP-ACP in enamel white spot lesions.

Full description

The aim of the study is to evaluate the caries prevention potential of pearl powder against CPP-ACP in enamel White Spot Lesions using laser fluorescence device scoring from 0 to 99, with daily application time of 3 months and follow up period of 6,9,and 12 months.

Enrollment

58 estimated patients

Sex

All

Ages

12 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • good oral hygiene
  • cooperative patient
  • completion of orthodontic therapy
  • presence of at least two white spot lesions on the labial surface of six maxillary anterior teeth, that were not present before orthodontic treatment

Exclusion criteria

  • bad oral hygiene
  • lack of patients compliance
  • allergy to milk products
  • pregnant or lactating women
  • presence of dentin caries, restorations, or enamel hypoplasia on maxillary anterior teeth
  • presence of periodontal pockets around maxillary anterior teeth

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

pearl powder
Experimental group
Description:
natural product, support bone and joint health
Treatment:
Other: pearl powder
CPP-ACP
Active Comparator group
Description:
product for professional use containing the active ingredient (CPP-ACP), a special milk-derived protein that has a unique ability to release bio-available calcium and phosphate to tooth surfaces.
Treatment:
Drug: CPP-ACP

Trial contacts and locations

0

Loading...

Central trial contact

Ruba A El Damarisy, MDS; omar shaalan, lecturer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems